Skip to main content
. 1997 Dec 9;94(25):13782–13785. doi: 10.1073/pnas.94.25.13782

Table 1.

Patients investigated

Don/Rec pair Diagnosis Age* Don/Rec Sex Don/Rec Blood group* Don/Rec Infused cells (×10−8/Kg) Recipient data at the time of the study
Months from BMT Blood group Cytogenetics CR
A AML 38/32 F/M B,+/B,+ 1.8 4 B,+ 46 XX Yes
B CML 39/32 M/M O,+/O,− 1.9 5 O,+ 46 XY Ph- Yes
C ALL 22/21 M/F O,+/O,+ 3.3 8 O,+ 46 XY Yes
D CML 51/38 M/F A,+/A,+ 2.6 9 A,+ 46 XY Ph- Yes
E AML 33/37 F/M A,+/A,+ 2.5 20 A,+ 46 XX Yes
F AML 42/44 F/F A,+/A,− 2.8 23 A,+ 46 XX Yes
G AML 8/12 F/F O,+/O,− 2.6 33 O,+ 46 XX Yes
H CML 28/37 M/M O,+/A,+ 2.7 37 O,+ 46 XY Ph- Yes
I CML 16/20 F/M O,+/A,+ 3.3 38 O,+ 46 XX Ph- Yes
J CML 33/37 F/F A,+/A,− 1.9 42 A,+ 46 XX Ph- Yes
K CML 24/29 M/M B,+/B,+ 2.1 83 B,+ 46 XY Ph- Yes

Don, bone marrow donor; Rec, bone marrow recipient; CR, complete remission; AML, acute myelogenous leukemia; ALL, acute lymphoblastic leukemia; CML, chronic myelogenous leukemia; ∗, at time of transplantation; +, Rh(D) blood group positive; −, Rh(D) blood group negative; Ph, absence of Philadelphia chromosome. 

Bold: data informative of allogeneic engraftment.